Today: 7 February 2026
Subscribe

Nebius Group N.V. (NBIS) Stock Ahead of December 1, 2025: Price, AI Mega‑Deals, Analyst Targets and 2026 Forecast

Nebius Group N.V. (NBIS) Stock Ahead of December 1, 2025: Price, AI Mega‑Deals, Analyst Targets and 2026 Forecast

Nebius Group N.V. (NASDAQ: NBIS), the Amsterdam‑based AI‑infrastructure specialist, heads into the new trading week around $94–95 per share, up well over 200% in 2025 but still about 30% below its recent 52‑week high of $141.10.Google+2nasdaq.com+2 From 28–30 November 2025, the stock was at the center of a fresh wave of analyst notes, hedge‑fund filings and opinion pieces that sharpened the bull and bear cases ahead of the Monday, 1 December 2025 U.S. market open. Key takeaways before the 1 December 2025 open Below is a structured look at price action, news, analysis and forecasts from 28–30 November 2025, plus
30 November 2025
Adobe Stock Forecast Before December 1, 2025 Open: AI Deals, Black Friday Record and Wall Street Targets for ADBE

Adobe Stock Forecast Before December 1, 2025 Open: AI Deals, Black Friday Record and Wall Street Targets for ADBE

As traders line up orders for the Monday, December 1, 2025 U.S. market open, Adobe Inc. (NASDAQ: ADBE) is heading into the new week with a strangely mixed setup: the business is delivering record AI-fueled results and holiday shopping data, yet the stock is pinned near its 52‑week low. Below is a deep dive into Adobe’s latest stock price action, the key news from November 28–30, 2025, and how Wall Street is positioning ADBE into December—based on public information available up to the weekend before the open. Adobe stock price snapshot going into December 1, 2025 Last close and trading
30 November 2025
·
Intuitive Surgical (ISRG) Stock Forecast for December 1, 2025: Price, News and Analysis Before the Bell

Intuitive Surgical (ISRG) Stock Forecast for December 1, 2025: Price, News and Analysis Before the Bell

As U.S. markets get ready to open on Monday, December 1, 2025, Intuitive Surgical, Inc. (NASDAQ: ISRG) heads into the new month sitting near the top of its 52‑week range after a powerful earnings rally, heavy institutional activity, and fresh AI‑driven research coverage. At the last full trading session on Friday, November 28, 2025, Intuitive Surgical stock closed around $573.5 per share, down only a fraction on the day but up strongly over the past month and quarter. That price implies a market capitalization of roughly $203–205 billion and leaves the stock less than 10% below recent 52‑week highs in
30 November 2025
·
McDonald’s (MCD) Stock Outlook Before the December 1, 2025 Open: Price, Dividend, Holiday Catalysts and Analyst Forecasts

McDonald’s (MCD) Stock Outlook Before the December 1, 2025 Open: Price, Dividend, Holiday Catalysts and Analyst Forecasts

McDonald’s Corporation (NYSE: MCD) heads into the new trading week with its stock sitting just below Wall Street’s fair‑value estimates, a fresh dividend hike about to go ex‑dividend, and a flurry of holiday promotions designed to keep budget‑stretched consumers coming through the door. As of the close on Friday, November 28, 2025, McDonald’s stock finished at $311.82, down 0.3% on the day, implying a market capitalization of roughly $222–223 billion.WallStreetZen+1 With U.S. markets shut over the weekend, that November 28 close is the reference point for traders watching how MCD behaves before and just after the opening bell on Monday,
30 November 2025
·
Chevron (CVX) Stock Outlook Before the December 1, 2025 Open: Price, News, Analysis and Forecast

Chevron (CVX) Stock Outlook Before the December 1, 2025 Open: Price, News, Analysis and Forecast

As Wall Street heads into the final month of 2025, Chevron Corporation (NYSE: CVX) enters Monday’s U.S. session trading just above $151 per share, about 10.5% below its 52‑week high near $168.96 and comfortably above its spring lows around $132. MarketWatch+2FinanceCharts+2 The stock has underperformed the S&P 500 over the past year, weighed down by softer oil prices and company‑specific operational and legal issues, yet it still offers a dividend yield around 4.6% and an aggressive share‑repurchase program – a combination that keeps Chevron firmly on the radar of income and value‑oriented investors. goagwest.com+2Finviz+2 Below is a detailed, news‑driven look
30 November 2025
Caterpillar (CAT) Stock Outlook Before the December 1, 2025 Open: Price, News, Analyst Ratings and AI-Driven Forecast

Caterpillar (CAT) Stock Outlook Before the December 1, 2025 Open: Price, News, Analyst Ratings and AI-Driven Forecast

As Wall Street heads into the first trading day of December 2025, Caterpillar Inc. (NYSE: CAT) is sitting near record highs, riding a powerful mix of AI‑driven energy demand, robust earnings – and mounting questions about tariffs and valuation. Below is a comprehensive look at Caterpillar’s stock price, the key news and analysis from November 28–30, 2025, and what it all could mean for CAT shares before the market opens on Monday, December 1, 2025. 1. Caterpillar (CAT) stock price snapshot after November 28 close U.S. markets were open for a shortened post‑Thanksgiving session on Friday, November 28, 2025. Caterpillar
30 November 2025
·
Pfizer (PFE) Stock Outlook Before the December 1, 2025 Open: Price, Metsera Obesity Deal, Dividend Payout and Wall Street Forecasts

Pfizer (PFE) Stock Outlook Before the December 1, 2025 Open: Price, Metsera Obesity Deal, Dividend Payout and Wall Street Forecasts

As U.S. markets prepare to reopen on Monday, December 1, 2025, Pfizer Inc. (NYSE: PFE) heads into the new week trading in a tight range but surrounded by a flurry of fresh analysis, institutional activity and strategic news from November 28–30. At the close on Friday, November 28, 2025, Pfizer shares finished around $25.74, giving the drugmaker a market capitalization of roughly $146 billion.Stock Titan With U.S. equity markets shut over the weekend, that closing print is the key reference point for investors going into Monday’s session. In this pre‑open update, we break down Pfizer’s latest stock price action, key
30 November 2025
··
Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Pfizer Stock Price Today (PFE): TrumpRx Drug Deal, $10B Metsera Buyout and 2026 Forecast

Updated November 30, 2025 Pfizer stock is in the middle of a big reset. The COVID windfall is fading, but a massive obesity-drug acquisition, a landmark bladder‑cancer approval and a high dividend yield are reshaping the story investors see in PFE. Pfizer stock price today: valuation snapshot As of the last trading session on Friday, November 28, Pfizer Inc. (NYSE: PFE) closed at $25.74 per share. That gives the company a market capitalization of roughly $146 billion. Investing.com Key current metrics: Pfizer’s share price is still down sharply from its 2021–2022 COVID peak above $50, so even after a modest 2025 rebound, the stock
30 November 2025
·
GE Vernova (GEV) Stock Outlook Before the December 1, 2025 Open: Taiwan Wind Deal, AI Power Demand and Rich Valuations

GE Vernova (GEV) Stock Outlook Before the December 1, 2025 Open: Taiwan Wind Deal, AI Power Demand and Rich Valuations

As Wall Street heads into the first trading day of December, GE Vernova Inc. (NYSE: GEV) is set to open Monday, December 1, 2025, near $600 a share after a powerful late‑November run fueled by strong earnings momentum, new international wind contracts and a flood of fresh research coverage.GE Vernova+2Finviz+2 Between November 28 and November 30, financial media, quant platforms and analysts pushed out a concentrated burst of updates on GE Vernova’s outlook. Here’s how that three‑day news window is shaping expectations before the bell. 1. Where GE Vernova Stock Stands Heading Into Monday Price and performance Trading volume on
30 November 2025
·
Nebius Stock Price Today (NBIS): Meta and Microsoft AI Deals, Q3 Earnings Shock, and 2026 Forecast – 30 November 2025

Nebius Stock Price Today (NBIS): Meta and Microsoft AI Deals, Q3 Earnings Shock, and 2026 Forecast – 30 November 2025

Ticker: Nebius Group N.V. (NASDAQ: NBIS)Date: 30 November 2025 Nebius (NBIS) stock price today: quick snapshot As of the close of U.S. trading on Friday, 28 November 2025, Nebius Group N.V.: On basic valuation measures, Nebius looks expensive by traditional standards: So, Nebius stock today is a classic hyper‑growth AI story: huge run‑up, big swings, and valuations that assume the company can keep executing almost perfectly. What Nebius actually does Nebius is a Dutch technology company building full‑stack cloud infrastructure for AI, not a consumer‑internet or ad business. Nebius+2Nebius+2 Key points: Nebius emerged out of a complex restructuring of Yandex N.V., with the AI infrastructure business carved out into
30 November 2025
Merck Stock (MRK) in November 2025: Price, Latest News, Forecasts and Analyst Outlook

Merck Stock (MRK) in November 2025: Price, Latest News, Forecasts and Analyst Outlook

Merck & Co. (NYSE: MRK) is ending November 2025 on a strong note. A flurry of regulatory wins for cancer drug Keytruda, positive mid‑stage data for heart drug Winrevair, and fresh deal‑making have pushed the share price close to its 52‑week high and reignited debate about the stock’s upside as it heads toward the Keytruda patent cliff later this decade. Below is a detailed, news‑driven look at Merck’s stock price, the latest company developments, and what Wall Street and various forecasting models are projecting from here, as of 30 November 2025. Merck stock price today: MRK near its 52‑week high As
30 November 2025
Opendoor Stock Price Today: OPEN’s AI Pivot, Warrant Dividend and 2026 Forecasts (November 30, 2025)

Opendoor Stock Price Today: OPEN’s AI Pivot, Warrant Dividend and 2026 Forecasts (November 30, 2025)

Opendoor Technologies (NASDAQ: OPEN) has gone from penny‑stock territory to one of 2025’s wildest meme‑stock comebacks. The company is tearing up its old playbook, refounding itself as an AI‑first software business, and handing shareholders a special dividend of tradable warrants — all while its core home‑flipping operation remains unprofitable and analysts warn of steep downside. Here’s a full breakdown of Opendoor’s stock price, latest news, AI strategy, warrant dividend, and Wall Street forecasts as of November 30, 2025. Note: This article is informational only and is not investment advice. Opendoor stock price today and recent performance As of the latest close on Friday, November 28,
30 November 2025
··
US Stock Market Forecast 2025: What Wall Street Expects Into Year‑End After the Fed Pivot

US Stock Market Forecast 2025: What Wall Street Expects Into Year‑End After the Fed Pivot

Published: November 30, 2025 – Not investment advice. Key takeaways 1. Where the US market stands on 30 November 2025 US equities reach the final month of 2025 in a position that would have sounded ambitious back in 2022: Market focus right now is split between two big forces: After cutting rates in October to a 3.75–4.00% federal‑funds range, the Fed is widely expected to trim again by 25 bps at its December meeting, which would take the range down to 3.50–3.75%. Trading Economics+2Reuters+2 That combination – lower rates, moderating inflation and strong tech earnings – is the backdrop for forecasts into year‑end.
30 November 2025
··
Citigroup (C) Stock Before the Market Opens on December 1, 2025: Latest News, Analyst Targets and Big-Money Moves

Citigroup (C) Stock Before the Market Opens on December 1, 2025: Latest News, Analyst Targets and Big-Money Moves

As U.S. markets head into the Monday, December 1, 2025 open, Citigroup Inc. (NYSE: C) is coming off one of its strongest stretches in years. The stock finished Friday around $103.60, just below its 52‑week high of $105.59 and up roughly 45–48% year‑to‑date, significantly ahead of the S&P 500’s gain. Barchart.com+1 Between November 28–30, a burst of fresh research, institutional filings and valuation work has reshaped the conversation around Citi heading into the new week. Here’s a detailed pre‑market look at where things stand, what changed over the last three days, and what traders and long‑term investors will likely be
30 November 2025
AbbVie (ABBV) Stock Outlook Before the December 1, 2025 Open: Skyrizi’s Canada Win, Medicare Cuts and Fresh Analyst Targets

AbbVie (ABBV) Stock Outlook Before the December 1, 2025 Open: Skyrizi’s Canada Win, Medicare Cuts and Fresh Analyst Targets

AbbVie Inc. (NYSE: ABBV) heads into Monday’s December 1, 2025 open sitting near the middle of its recent trading range, with a lot of fresh information for investors to digest from November 28–30. As of the latest close on November 30, AbbVie shares are trading in the mid‑$220s — around $227 per share — after a strong year (roughly 30%+ total return over the past 12 months) but a softer week in which the stock slipped about 3% as traders reacted to Medicare pricing headlines and year‑end profit‑taking. TS2 Tech+1 At this level the stock offers a dividend yield a
30 November 2025
·
Charles Schwab (SCHW) Stock Outlook Before the December 1, 2025 Open: Pre‑Market Moves, Analyst Targets and New Fee Plans

Charles Schwab (SCHW) Stock Outlook Before the December 1, 2025 Open: Pre‑Market Moves, Analyst Targets and New Fee Plans

As investors head into the first trading day of December 2025, The Charles Schwab Corporation (NYSE: SCHW) sits close to its yearly highs after a strong Thanksgiving week rally, but with a growing debate over interest‑rate risk, new fee structures, and an ambitious push into private markets. Schwab shares closed at $92.73 on Friday, November 28, up about 1.0% on the shortened post‑holiday session and extending a five‑day winning streak. MarketWatch The stock now trades near the upper end of its 52‑week range of $65.88–$99.59, roughly 40% above the low and about 7% below the high. Investing.com+1 Ahead of Monday’s
30 November 2025
Merck Stock (MRK) Outlook Before the December 1, 2025 Market Open: Rally, Ratings and Pipeline Catalysts

Merck Stock (MRK) Outlook Before the December 1, 2025 Market Open: Rally, Ratings and Pipeline Catalysts

Merck & Co., Inc. (NYSE: MRK) heads into the Monday, December 1, 2025 market open riding one of the strongest monthly rallies in the S&P 500, powered by upbeat earnings, dividend growth and a string of bullish analyst calls focused on its post‑Keytruda pipeline.Barron’s+1 Below is a detailed look at how MRK is positioned before the bell, based on news, forecasts and analysis published between November 28–30, 2025. Note: This article is for informational and educational purposes only and is not investment advice. 1. Where Merck Stock Stands After November’s Surge Price and recent performance One of November’s standout winners
30 November 2025
Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

Omnicom Group (OMC) Stock Before the Bell on December 1, 2025: IPG Mega‑Merger, Dividend Hike and Debt Exchange Put Shares at a Crossroads

As U.S. markets head into the open on Monday, December 1, 2025, Omnicom Group Inc. (NYSE: OMC) is one of the most event‑packed names in the advertising sector. After a week that saw the Interpublic Group (IPG) mega‑merger close, a multi‑billion‑dollar debt exchange wrap up, and a double‑digit dividend hike, Omnicom stock goes into December priced like a value name but carrying all the execution risk of a newly formed global giant. StockAnalysis+2TS2 Tech+2 Below is a detailed, news‑driven look at where OMC stands before Monday’s open, based on all the major news, forecasts and analyses published between 28–30 November
30 November 2025
····
Booking Holdings (BKNG) Stock Outlook Before the December 1, 2025 Market Open: Q3 Beat, AI Push and Heavy Institutional Trading

Booking Holdings (BKNG) Stock Outlook Before the December 1, 2025 Market Open: Q3 Beat, AI Push and Heavy Institutional Trading

As U.S. markets get ready to reopen on Monday, December 1, 2025, Booking Holdings Inc. Common Stock (NASDAQ: BKNG) heads into the new week at a critical juncture: fundamentals look very strong, analyst targets imply double‑digit upside, but the share price is still lagging both its own highs and the broader market. At Friday’s close on November 28, BKNG was trading around $4,900–$4,920 per share, with after‑hours data showing only a small dip to roughly $4,909.MarketBeat That leaves the stock about 16% below its 52‑week high near $5,839, despite a recent rally in late November.MarketWatch+1 The last three days of
30 November 2025
··
Shopify Stock Before the Open on December 1, 2025: Black Friday Record, Layoffs and 2026 Price Targets

Shopify Stock Before the Open on December 1, 2025: Black Friday Record, Layoffs and 2026 Price Targets

As U.S. markets head into Cyber Monday on Monday, December 1, 2025, Shopify Inc. (ticker: SHOP) enters December trading with a mix of powerful tailwinds and fresh risks that could shape how the stock trades at the open. The e‑commerce platform just reported record Black Friday sales of $6.2 billion for its merchants, confirmed new but small layoffs, faces regulatory pressure over illegal vape sellers, and still trades at premium valuations even as analyst targets cluster in the $165–$200 range.Ticker Nerd+3AP News+3Reuters+3 Below is a detailed look at where Shopify stands before the bell on December 1, and the key
30 November 2025
··
1 … 1,171 1,172 1,173 1,174 1,175 … 1,631

Stock Market Today

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

MARA stock jumps 22% into weekend as bitcoin whipsaws; Monday risk test looms

7 February 2026
MARA shares jumped 22.4% to $8.24 Friday, trading higher after hours, as the company moved $87 million in bitcoin to major custodians. About 82.4 million MARA shares changed hands. Bitcoin hovered near $68,928 Saturday. A MARA filing showed its general counsel had shares withheld for taxes on vested stock units, not an open market sale.
Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

Apple stock (AAPL) set for Monday test as memory-chip crunch revives iPhone price question

7 February 2026
Apple shares closed up 0.8% at $278.12 Friday, then slipped 0.3% after hours. A global DRAM shortage is raising component costs, putting pressure on Apple’s pricing ahead of its Feb. 24 shareholder meeting. CEO Tim Cook said memory prices will rise “sharply” but gave no details on possible iPhone price hikes. Investors await signals before next week’s U.S. inflation data.
Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

Roivant stock surges on brepocitinib skin-disease data; what to watch into Monday

7 February 2026
Roivant shares surged 22.4% to $25.82 after Phase 2 data showed its drug brepocitinib outperformed placebo in cutaneous sarcoidosis, with no serious adverse events. The company plans a Phase 3 trial in 2026 and has filed for FDA approval in dermatomyositis. Quarterly revenue reached $2 million, with a $313.7 million loss. Cash holdings stood at $4.5 billion.
Go toTop